Vaidya N, Acharya N, Katila S, Adhikari S, Pandey U
Ann Med Surg (Lond). 2023; 85(10):5153-5157.
PMID: 37811011
PMC: 10553199.
DOI: 10.1097/MS9.0000000000001146.
Lu Q, Xu Y, Zhang Z, Li S, Zhang Z
Front Endocrinol (Lausanne). 2023; 14:1235040.
PMID: 37705574
PMC: 10497106.
DOI: 10.3389/fendo.2023.1235040.
Lv X, Gao F, Cao X
Cell Metab. 2022; 34(12):1914-1931.
PMID: 36257317
PMC: 9742337.
DOI: 10.1016/j.cmet.2022.09.025.
Lu Q, Xu Y, Li S, Zhang Z, Sheng J, Zhang Z
Int J Biol Sci. 2022; 18(9):3908-3917.
PMID: 35813463
PMC: 9254467.
DOI: 10.7150/ijbs.71261.
Qiao W, Pan D, Zheng Y, Wu S, Liu X, Chen Z
Nat Commun. 2022; 13(1):535.
PMID: 35087048
PMC: 8795158.
DOI: 10.1038/s41467-022-28203-0.
The first case of primary hypertrophic osteoarthropathy with soft tissue giant tumors caused by HPGD loss-of-function mutation.
Pang Q, Xu Y, Qi X, Jiang Y, Wang O, Li M
Endocr Connect. 2019; 8(6):736-744.
PMID: 31063976
PMC: 6547301.
DOI: 10.1530/EC-19-0149.
Pachydermoperiostosis (Touraine-Solente-Gole syndrome): a case report.
Joshi A, Nepal G, Shing Y, Panthi H, Baral S
J Med Case Rep. 2019; 13(1):39.
PMID: 30786934
PMC: 6383214.
DOI: 10.1186/s13256-018-1961-z.
Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis.
Chen H, Hu B, Lv X, Zhu S, Zhen G, Wan M
Nat Commun. 2019; 10(1):181.
PMID: 30643142
PMC: 6331599.
DOI: 10.1038/s41467-018-08097-7.
Novel SLCO2A1 mutations cause gender differentiated pachydermoperiostosis.
Yuan L, Chen X, Liu Z, Wu D, Lu J, Bao G
Endocr Connect. 2018; .
PMID: 30352415
PMC: 6223238.
DOI: 10.1530/EC-18-0326.
A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support.
Desai A, Zhang Y, Park Y, Dawson D, Larusch G, Kasturi L
Haematologica. 2018; 103(6):1054-1064.
PMID: 29472361
PMC: 6058768.
DOI: 10.3324/haematol.2017.178376.
Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.
Nakanishi T, Tamai I
AAPS J. 2017; 20(1):13.
PMID: 29204966
DOI: 10.1208/s12248-017-0163-8.
Pachydermoperiostosis: a rare mimicker of acromegaly.
Abdullah N, Jason W, Nasruddin A
Endocrinol Diabetes Metab Case Rep. 2017; 2017.
PMID: 28567291
PMC: 5445428.
DOI: 10.1530/EDM-17-0029.
Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.
Guda K, Fink S, Milne G, Molyneaux N, Ravi L, Lewis S
Cancer Prev Res (Phila). 2014; 7(8):805-12.
PMID: 24838973
PMC: 4125515.
DOI: 10.1158/1940-6207.CAPR-14-0108.
Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.
Zhang Z, Xia W, He J, Zhang Z, Ke Y, Yue H
Am J Hum Genet. 2011; 90(1):125-32.
PMID: 22197487
PMC: 3257902.
DOI: 10.1016/j.ajhg.2011.11.019.
Gastric juvenile polyposis with high-grade dysplasia in pachydermoperiostosis.
de Mestier L, Moreau S, Neuzillet C, Ruszniewski P, Panis Y, Hammel P
Case Rep Gastroenterol. 2011; 5(3):508-15.
PMID: 22087081
PMC: 3214683.
DOI: 10.1159/000326955.
Primary hypertrophic osteoarthropathy.
Poormoghim H, Hosseynian A, Javadi A
Rheumatol Int. 2010; 32(3):607-10.
PMID: 21125281
DOI: 10.1007/s00296-010-1667-z.
Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women.
Undale A, Srinivasan B, Drake M, McCready L, Atkinson E, Peterson J
Bone. 2010; 47(1):83-92.
PMID: 20362080
PMC: 2891408.
DOI: 10.1016/j.bone.2010.03.018.